gRNA Market Size Worth USD 3,171.65 Million By 2034 Fueled by Rapid Expansion of Gene Editing Applications

According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...

Teens may have come up with a new way to detect, treat Lyme disease using CRISPR gene editing

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

Lithuania's Edge: Leading in life sciences, laser innovations, and ethical AI

GDP & Rising The Lithuanian life sciences sector is growing at an annual rate of 30%, contributing 2.2% to the country’s GDP, and is expected to reach 5% by 2030. The country is recognized for ...
Le Lézard

ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

ToolGen Inc. (KOSDAQ: 199800), a leading genome editing company based in Korea, announced today that it has entered into a strategic cross-license agreement with GenEditBio Limited ("GenEditBio"), a ...

Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics

Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.